Production (Stage)
Asia Green Biotechnology Corp.
ASIA
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 24.10K | 63.10K | 25.30K | 89.00K | 7.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.10K | 63.10K | 25.30K | 89.00K | 7.70K |
| Operating Income | -24.10K | -63.10K | -25.30K | -89.00K | -7.70K |
| Income Before Tax | -32.10K | -78.50K | -34.20K | -112.50K | -17.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -32.10K | -78.50K | -34.20K | -112.50K | -17.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.10K | -78.50K | -34.20K | -112.50K | -17.90K |
| EBIT | -24.10K | -63.10K | -25.30K | -89.00K | -7.70K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 36.25M | 36.25M | 36.25M | 36.25M | 36.25M |
| Average Diluted Shares Outstanding | 36.25M | 36.25M | 36.25M | 36.25M | 36.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |